抗胸腺细胞 meaning in Chinese

antithymocyte

Median follow - up was 377 days . one patient in the thymoglobulin group who suffered primary graft nonfunction died
平均随访377天,使用抗胸腺细胞球蛋白组1例患者死于移植物原发性失功
Abstract ： immunosuppression for immunologically high - risk renal transplant patients usually inoles antithymocyte globulin induction with triple drug maintenance therapy
摘要:肾移植免疫高危患者的免疫抑制方案通常是予抗胸腺细胞球蛋白诱导免疫抑制,然后以三联免疫抑制药物维持治疗